Search research articles
Contact Us
Filters
Showing results (421-430 of 548) with videos related to
Page
of 55
Sort By:
European Journal of Pharmacology
|
September 30, 1983
Elevation of circulating prolactin concentrations may not cause striatal dopamine receptor supersensitivity
N Rupniak, M Hong, S Mansfield, et al.
British Journal of Pharmacology
|
July 1, 1979
Central properties of alpha-allophanyl-alpha-allyl-gamma-valerolactone (valofan) [proceedings]
A Clow, P Jenner, C D Marsden, et al.
Annals of Neurology
|
September 1, 1994
Glutathione-related enzymes in brain in Parkinson's disease
J Sian, D T Dexter, A J Lees, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)
|
April 21, 2007
L-dopa dose and the duration and severity of dyskinesia in primed MPTP-treated primates
M Kuoppamäki, G Al-Barghouthy, M J Jackson, et al.
European Journal of Pharmacology
|
May 31, 1990
1-Methyl-4-(2'-methylphenyl)-1,2,3,6-tetrahydropyridine (2'-methyl-MPTP) is less neurotoxic than MPTP in the common marmoset
S Rose, M Nomoto, E A Jackson, et al.
Journal of Bacteriology
|
July 11, 1998
Expression of a gene for a porin-like protein of the OmpA family from Mycobacterium tuberculosis H37Rv
R H Senaratne, H Mobasheri, K G Papavinasasundaram, et al.
Neuroscience Letters
|
May 19, 1987
Analogues of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine as monoamine oxidase substrates: a second ring is not necessary
C Gibb, J Willoughby, V Glover, et al.
Journal of Neurochemistry
|
March 1, 1990
Mitochondrial complex I deficiency in Parkinson's disease
A H Schapira, J M Cooper, D Dexter, et al.
Journal of Neurochemistry
|
September 1, 1997
A generalised increase in protein carbonyls in the brain in Parkinson's but not incidental Lewy body disease
Z I Alam, S E Daniel, A J Lees, et al.
Neuropharmacology
|
May 1, 1984
Behavioural and biochemical alterations in the function of dopamine receptors following repeated administration of L-DOPA to rats
M D Hall, D R Cooper, S Fleminger, et al.
Page
of 55
Search research articles
Search
Showing results (421-430 of 548) with videos related to
Sort By:
Page
of 55
European Journal of Pharmacology
|
September 30, 1983
Elevation of circulating prolactin concentrations may not cause striatal dopamine receptor supersensitivity
N Rupniak, M Hong, S Mansfield, et al.
British Journal of Pharmacology
|
July 1, 1979
Central properties of alpha-allophanyl-alpha-allyl-gamma-valerolactone (valofan) [proceedings]
A Clow, P Jenner, C D Marsden, et al.
Annals of Neurology
|
September 1, 1994
Glutathione-related enzymes in brain in Parkinson's disease
J Sian, D T Dexter, A J Lees, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)
|
April 21, 2007
L-dopa dose and the duration and severity of dyskinesia in primed MPTP-treated primates
M Kuoppamäki, G Al-Barghouthy, M J Jackson, et al.
European Journal of Pharmacology
|
May 31, 1990
1-Methyl-4-(2'-methylphenyl)-1,2,3,6-tetrahydropyridine (2'-methyl-MPTP) is less neurotoxic than MPTP in the common marmoset
S Rose, M Nomoto, E A Jackson, et al.
Journal of Bacteriology
|
July 11, 1998
Expression of a gene for a porin-like protein of the OmpA family from Mycobacterium tuberculosis H37Rv
R H Senaratne, H Mobasheri, K G Papavinasasundaram, et al.
Neuroscience Letters
|
May 19, 1987
Analogues of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine as monoamine oxidase substrates: a second ring is not necessary
C Gibb, J Willoughby, V Glover, et al.
Journal of Neurochemistry
|
March 1, 1990
Mitochondrial complex I deficiency in Parkinson's disease
A H Schapira, J M Cooper, D Dexter, et al.
Journal of Neurochemistry
|
September 1, 1997
A generalised increase in protein carbonyls in the brain in Parkinson's but not incidental Lewy body disease
Z I Alam, S E Daniel, A J Lees, et al.
Neuropharmacology
|
May 1, 1984
Behavioural and biochemical alterations in the function of dopamine receptors following repeated administration of L-DOPA to rats
M D Hall, D R Cooper, S Fleminger, et al.
Page
of 55